CN Patent

CN112957332B — 注射用磷酸特地唑胺及其质量标准

Assigned to Hainan General & Comrie Pharmaceutical Co ltd · Expires 2023-04-25 · 3y expired

What this patent protects

本发明涉及的药物制剂技术领域,尤其涉及一种注射用磷酸特地唑胺及其质量标准。注射用磷酸特地唑铵,其为冻干粉针剂,由包括如下重量份数的原料制备而成:磷酸特地唑胺150‑250份;甘露醇85‑125份;羧甲基纤维素钠0‑60份;2mol/L氢氧化钠350‑500份;注射用水1600‑2400份;所述注射用磷酸特地唑胺冻干粉针剂中注射用水的含量为2‑2.8%。该冻干粉针剂稳定性高,不易受环境变化影响。注射用磷酸特地唑铵质量标准,包括水分含量测定、速溶性测定、澄清度与颜色测定、有关物质测定、异构体测定以及含量测定。符合本发明质量标准的注射用磷酸特地唑胺冻干粉针剂同…

USPTO Abstract

本发明涉及的药物制剂技术领域,尤其涉及一种注射用磷酸特地唑胺及其质量标准。注射用磷酸特地唑铵,其为冻干粉针剂,由包括如下重量份数的原料制备而成:磷酸特地唑胺150‑250份;甘露醇85‑125份;羧甲基纤维素钠0‑60份;2mol/L氢氧化钠350‑500份;注射用水1600‑2400份;所述注射用磷酸特地唑胺冻干粉针剂中注射用水的含量为2‑2.8%。该冻干粉针剂稳定性高,不易受环境变化影响。注射用磷酸特地唑铵质量标准,包括水分含量测定、速溶性测定、澄清度与颜色测定、有关物质测定、异构体测定以及含量测定。符合本发明质量标准的注射用磷酸特地唑胺冻干粉针剂同样具有稳定性高、不易受环境变化影响的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN112957332B
Jurisdiction
CN
Classification
Expires
2023-04-25
Drug substance claim
No
Drug product claim
No
Assignee
Hainan General & Comrie Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.